|
31.01.2018 22:24:03
|
Vertex Pharmaceuticals Inc. Reveals Advance In Q4 Profit
(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) reported a profit for its fourth quarter that gained ground compared to the same period last year.
The company said its bottom line climbed to $158 million, or $0.61 per share. This was up from $88 million, or $0.35 per share, in last year's fourth quarter.
Analysts had expected the company to earn $0.53 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company said revenue for the quarter rose 42.1% to $651.63 million. This was up from $458.71 million last year.
Vertex Pharmaceuticals Inc. earnings at a glance:
-Earnings (Q4): $158 Mln. vs. $88 Mln. last year. -Earnings Growth (Y-o-Y): 79.5% -EPS (Q4): $0.61 vs. $0.35 last year. -EPS Growth (Y-o-Y): 74.3% -Analysts Estimate: $0.53 -Revenue (Q4): $651.63 Mln vs. $458.71 Mln last year. -Revenue Change (Y-o-Y): 42.1%
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Vertex Pharmaceuticals Inc.mehr Nachrichten
Analysen zu Vertex Pharmaceuticals Inc.mehr Analysen
Aktien in diesem Artikel
| Vertex Pharmaceuticals Inc. | 448,35 | -0,58% |
|
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.